TickerFacts.

Estrella Immunopharma, Inc. (ESLA): Shareholders' Equity

Annual figures by period end, from SEC filings.

-$10.37M
As of 2025-12-31
-$7.43M
As of 2026-06-30
$4.27M2021-12-31: -$1.01M2022-12-31: -$2.26M2023-06-30: -$11.74M2024-06-30: $4.27M2024-12-31: $143.7K2025-12-31: -$10.37M-$10.37M
2021-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31-$10.37Mn/m2026-03-18, Balance as of period end
2024-12-31$143.7Kn/a2026-03-18, Balance as of period end
2024-06-30$4.27Mn/m2024-09-27, Balance as of period end
2023-06-30-$11.74Mn/a2024-09-27, Balance as of period end
2022-12-31-$2.26Mn/m2023-03-14, Balance as of period end
2021-12-31-$1.01Mn/a2023-03-14, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Biological Products, (No Diagnostic Substances)), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Estrella Immunopharma, Inc. (ESLA)2025-12-31-$10.37Mn/m
BioCardia, Inc. (BCDA)2025-12-31$895.0K+6.9%
Cero Therapeutics Holdings, Inc. (CERO)2025-12-31-$5.45Mn/m
Tevogen Inc. (TVGN)2025-12-31-$8.23Mn/m
Eloxx Pharmaceuticals, Inc. (ELOX)2025-12-31-$11.91Mn/m
AIM ImmunoTech Inc. (AIM)2025-12-31-$9.78Mn/m
Exozymes Inc. (EXOZ)2025-12-31$3.40M-67.4%
Zivo Bioscience, Inc. (ZIVO)2024-12-31-$514.9Kn/m
Zeo ScientifiX, Inc. (ZEOX)2025-10-31-$1.42Mn/m

Compare ESLA, BCDA, CERO, TVGN side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗